共 50 条
- [22] Re: Rustom P. Manecksha, Ivor M. Cullen, Sarfraz Ahmad, et al. Prospective Randomised Controlled Trial Comparing Trigone-Sparing versus Trigone-Including Intradetrusor Injection of AbobotulinumtoxinA for Refractory Idiopathic Detrusor Overactivity. Eur Urol 2012;61:928-35 EUROPEAN UROLOGY, 2012, 61 (05) : E41 - E41
- [24] Re: Bontzos et al.: Nonresponders to Ranibizumab Anti-VEGF Treatment Are Actually Short-term Responders: A Prospective Spectral-Domain OCT Study (Ophthalmol Retina. 2020;4: 1138-1145) OPHTHALMOLOGY RETINA, 2021, 5 (03): : E3 - E3
- [25] Re: Bontzos et al.: Nonresponders to Ranibizumab Anti-VEGF Treatment Are Actually Short-term Responders: A Prospective Spectral-Domain OCT Study (Ophthalmol Retina. 2020;4: 1138-1145) REPLY OPHTHALMOLOGY RETINA, 2021, 5 (03): : E4 - E4
- [27] Re: Maria S. Lindgren, Peter Bue, Nessn Azawi, et al. The DaBlaCa-13 Study: Short-term, Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in Non-muscle-invasive Bladder Cancer-A Randomized Controlled Trial. Eur Urol 2020;78:856-62 EUROPEAN UROLOGY, 2021, 79 (05) : E135 - E136
- [28] Re: Renzo Colombo, Lorenzo Rocchini, Nazareno Suardi, et al. Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurrent Non-muscle-invasive Bladder Cancer: Preliminary Results of a Randomised Phase 2 Study. Eur Urol 2012;62:797-802 EUROPEAN UROLOGY, 2013, 63 (01) : E6 - E6
- [30] Re: Pak et al.: Utilization Trends and Short-term Outcomes of Robotic Versus Open Radical Cystectomy for Bladder Cancer (Urology 2017; 103: 117-123) and Borza et al.: No Differences in Population-based Readmissions After Open and Robotic-assisted Cystectomy: Implications for Post-discharge Care (Urology 2017; 104: 77-83) UROLOGY, 2017, 105 : 211 - 211